Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Klein

Showing results (21-30 of 377) with videos related to

Pageof 38
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicityGrzegorz Terszowski, Christian Klein, Martin Stern
Proceedings. Mathematical, Physical, and Engineering Sciences|December 9, 2014
Numerical study of fractional nonlinear Schrödinger equationsChristian Klein, Christof Sparber, Peter Markowich
Oncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan Stilgenbauer
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
Acta Crystallographica. Section C, Structural Chemistry|July 5, 2024
Synthesis, spectroscopic and crystallographic characterization of various cymantrenyl thioethers [Mn{C<sub>5</sub>H<sub>x</sub>Br<sub>y</sub>(SMe)<sub>z</sub>}(PPh<sub>3</sub>)(CO)<sub>2</sub>]Christian Klein-Hessling, Tobias Blockhaus, Karlheinz Sünkel
Mabs|June 11, 2016
The use of CrossMAb technology for the generation of bi- and multispecific antibodiesChristian Klein, Wolfgang Schaefer, Jörg T Regula
Expert Opinion on Biological Therapy|January 11, 2023
Rationale for combining tyrosine kinase inhibitors and T cell redirecting antibodies to mitigate cytokine release syndrome (CRS)Gabrielle Leclercq-Cohen, Marina Bacac, Christian Klein
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|June 22, 2010
Nonlinear associations between chronic stress and cardiovascular reactivity and recoveryDavid K Chatkoff, Karl J Maier, Christian Klein
Electronic Markets|August 31, 2022
Invite everyone to the table, but not to every course: How Design-Thinking collaboration can be implemented in smart cities to design digital servicesFrederike Marie Oschinsky, Hans Christian Klein, Bjoern Niehaves
Oncoimmunology|September 26, 2015
How to outsmart NK cell toleranceGrzegorz Terszowski, Christian Klein, Laurent Schmied, et al.
Pageof 38

Showing results (21-30 of 377) with videos related to

Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2014
KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicityGrzegorz Terszowski, Christian Klein, Martin Stern
Proceedings. Mathematical, Physical, and Engineering Sciences|December 9, 2014
Numerical study of fractional nonlinear Schrödinger equationsChristian Klein, Christof Sparber, Peter Markowich
Oncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan Stilgenbauer
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
Acta Crystallographica. Section C, Structural Chemistry|July 5, 2024
Synthesis, spectroscopic and crystallographic characterization of various cymantrenyl thioethers [Mn{C<sub>5</sub>H<sub>x</sub>Br<sub>y</sub>(SMe)<sub>z</sub>}(PPh<sub>3</sub>)(CO)<sub>2</sub>]Christian Klein-Hessling, Tobias Blockhaus, Karlheinz Sünkel
Mabs|June 11, 2016
The use of CrossMAb technology for the generation of bi- and multispecific antibodiesChristian Klein, Wolfgang Schaefer, Jörg T Regula
Expert Opinion on Biological Therapy|January 11, 2023
Rationale for combining tyrosine kinase inhibitors and T cell redirecting antibodies to mitigate cytokine release syndrome (CRS)Gabrielle Leclercq-Cohen, Marina Bacac, Christian Klein
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|June 22, 2010
Nonlinear associations between chronic stress and cardiovascular reactivity and recoveryDavid K Chatkoff, Karl J Maier, Christian Klein
Electronic Markets|August 31, 2022
Invite everyone to the table, but not to every course: How Design-Thinking collaboration can be implemented in smart cities to design digital servicesFrederike Marie Oschinsky, Hans Christian Klein, Bjoern Niehaves
Oncoimmunology|September 26, 2015
How to outsmart NK cell toleranceGrzegorz Terszowski, Christian Klein, Laurent Schmied, et al.
Pageof 38